MELISSA BOOTHE: Open Payments
NPI 1023298163 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,916 in 174 payments from 26 companies in 2025. Trend: 2023 $4,683 · 2024 $4,391 · 2025 $4,916
Food & beverage: $4,916
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $512 |
| GENZYME CORPORATION | 9 | $465 |
| Galderma Laboratories, L.P. | 16 | $456 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $407 |
| Novartis Pharmaceuticals Corporation | 9 | $396 |
| ABBVIE INC. | 17 | $361 |
| Amgen Inc. | 14 | $332 |
| Regeneron Healthcare Solutions, Inc. | 10 | $307 |
| Janssen Biotech, Inc. | 12 | $281 |
| Lilly USA, LLC | 16 | $275 |
Products named: DUPIXENT, TREMFYA, Bimzelx, NEMLUVIO, SKYRIZI, ILUMYA, Otezla, SOFDRA.
Industry payments across NC — which companies pay providers there.
